Dynamics of nocodazole washout upon Mad2 overexpression. by Alma Beatrix Stier (20903134)

Discovery of D25, a Potent and Selective MNK Inhibitor for Sepsis-Associated Acute Spleen Injury by Qiang Li (8118)

“…This study undertakes the modification of a 4-(3-(piperidin-4-yl)-1<i>H</i>-pyrazol-5-yl)pyridine structure, leading to the discovery of 4-(3-(piperidin-4-yl)-1<i>H</i>-pyrazol-5-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (D25) as a potent and selective MNK inhibitor. …”

Knockdown of NG2 by siRNA results in decreased viability and a reduction in PARP levels. by Frank Maus (792209)

Can we use rapid lifetime determination for fast, fluorescence lifetime based, metabolic imaging? Precision and accuracy of double-exponential decay measurements with low total cou... by Susana Figueiredo Silva (6697223)

Results on the trimmed datasets with a decreasing number of papers per author available for training and testing. by Leonard Bauersfeld (16475015)

Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms by Andrea Corsello (5172026)

“…</p><p>Results</p><p>Patients with ileal or pancreatic NENs showed increased plasma levels of total-CgA and CgA_1-76 fragment (vasostatin-1, VS-1) compared to controls [median (25^th-75^th-percentiles); total-CgA: 1.85 nM (1.01–4.28) <i>vs</i> 0.75 nM (0.52–0.89), <i>p</i> = 0.004; VS-1: 2.76 nM (1.09–7.10) <i>vs</i> 0.29 nM (0.26–0.32), <i>p</i><0.001, respectively], but not of CgA_1-439 or CgA_1-373 fragment. …”

Decreased cell proliferation in the PP-treated infarcted heart in a mouse model of myocardial infarction. by Motoaki Murakoshi (479700)

Decreased expression of synaptopodin and RhoA. by Sandra Müller-Krebs (485766)

Decrease of the viral infectivity titer by marchantins. by Yuma Iwai (220294)

“…The cells were then treated with various concentrations of phytochemicals (3.1–50 µM), some of which decreased viral infectivity titer. …”

Inhibition of coactivator expression by RNAi decreases PPARα activity in a ligand-specific manner by Eric S. Tien (22393)

Purified apolipoproteins decrease endothelial exocytosis. by Scott J. Cameron (838315)

p120ctn depletion decreases directional persistence of cells migrating into a scratch wound. by Sandra Kümper (245458)

Simulated effects of increased pCREB combined with decreased pCaMKIIα on bistability. by Yili Zhang (540283)

“…However, decreasing <i>k</i>_{<i>basalp_CaMKII</i>} by ~50% blocked the bistable switch (red). …”

K562 cells treated with 25, 50, and 75 μM of hemin for 48 h. by Tipparat Penglong (164413)

m 6A RNA Methylation Decreases Atherosclerotic Vulnerable Plaque Through Inducing T Cells by Chunmei Qi (739294)

“…Conclusion: After successfully establishing a vascular parkinsonism rabbit model, m 6A RNA methylation can decrease Th cells and vulnerable atherosclerotic plaques.…”

NEMO knockout murine dermal fibroblasts show a decreased nuclear translocation of p65. by Patrick Meyer (3395285)

Overexpression of DHCR24 on the cell surface of HCC cell lines was decreased by treatment with U18666A and cyclosporin A. by Makoto Saito (721667)

Trajectory scores decrease during learning. by Chenguang Zhang (457185)